Top Players Covered in the Contract Development and Manufacturing Organization Market Research Report

Contract Development and Manufacturing Organization Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2026 is latest study published by Fortune Business Insights. Global contract development and manufacturing organization market size is projected to reach USD 278.98 billion by the end of 2026. Mergers and acquisitions are a growing trend among major companies across the world. According to a report published by Fortune Business Insights, titled “Contract Development and Manufacturing Organization Market Size, Share & Industry Analysis, By Service {By CMO (API, Finished Product {Solid Dosage Forms, Injectables, and Others}, and Packaging)} {By CRO (Discovery, Preclinical, Clinical Trial, and Laboratory Services)} and Regional Forecast, 2019-2026,” the market was worth USD 130.80 billion in 2018 and will exhibit a CAGR of 10.0% during the forecast period, 2019-2026.
Please visit: https://www.fortunebusinessinsights.com/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502
List of companies profiled in the report:
· Catalent, Inc
· Baxter
· Vetter
· Recipharm AB
· Albany Molecular Research Inc. (AMRI)
· Thermo Fisher Scientific Inc. (Patheon)
· Unither
· DPT LABORATORIES LTD.
· NextPharma Technologies
· Others
Contract Development and Manufacturing Organization Market Segmentations:
By Service
• By CMO
o API Manufacturing
o Finished Product Manufacturing
o Solid Dosage Forms
o Injectables
o Others (Semisolids/liquid, powder)
o Packaging
• By CRO
o Discovery
o Preclinical
o Clinical
o Laboratory Services
By Geography
• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, and Rest of Asia Pacific)
• Rest of the World